The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Iota-Carrageenan is a potent inhibitor of rhinovirus infection
Open accessAbstract
BACKGROUND: Human rhinoviruses (HRVs) are the predominant cause of common cold. In addition, HRVs are implicated in the worsening of COPD and asthma, as well as the loss of lung transplants. Despite significant efforts, no anti-viral agent is approved for the prevention or treatment of HRV-infection. RESULTS: In this study we demonstrate that Iota-Carrageenan, a sulphated polysaccharide derived from red seaweed, is a potent anti-rhinoviral substance in-vitro. Iota-Carrageenan reduces HRV growth and inhibits the virus induced cythopathic effect of infected HeLa cells. In addition, Iota-Carrageenan effectively prevents the replication of HRV1A, HRV2, HRV8, HRV14, HRV16, HRV83 and HRV84 in primary human nasal epithelial cells in culture. The data suggest that Iota-Carrageenan acts primarily by preventing the binding or the entry of virions into the cells. CONCLUSION: Since HRV infections predominately occur in the nasal cavity and the upper respiratory tract, a targeted treatment with a product containing Iota-Carrageenan is conceivable. Clinical trials are needed to determine whether Iota-Carrageenan-based products are effective in the treatment or prophylaxis of HRV infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carrageenan is a potent inhibitor of papillomavirus infection
Buck, C. B., Thompson, C. D., Roberts, J. N., Müller, M., Lowy, D. R., & Schiller, J. T. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020069 · Cited by 497
Proud, D., Sanders, S. P., & Wiehler, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4637 · Cited by 154
Intranasal Interferon- 2, Treatment of Experimental Rhinoviral Colds
Hayden, F. G., & Gwaltney, J. M. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.2.174 · Cited by 109 · cited 1×
“[8-10].”
Combined antiviral-antimediator treatment for the common cold
Gwaltney, J. M., Winther, B., Patrie, J. T., & Hendley, J. O. (2002) · The Journal of Infectious Diseases · doi:10.1086/341455 · Cited by 69
Cited by
Necas, J., & Bartosikova, L. (2013) · Veterinární medicína · doi:10.17221/6758-vetmed · Cited by 929
Carrageenan: Drug Delivery Systems and Other Biomedical Applications
Pacheco-Quito, E.-M., Ruiz-Caro, R., & Veiga, M.-D. (2020) · Marine Drugs · doi:10.3390/md18110583 · Cited by 420
Brown, E. M., Allsopp, P. J., Magee, P. J., Gill, C. I., Nitecki, S., Strain, C. R., & McSorley, E. M. (2014) · Nutrition Reviews · doi:10.1111/nure.12091 · Cited by 392
RETRACTED: Carrageenan: A natural seaweed polysaccharide and its applications
Prajapati, V. D., Maheriya, P. M., Jani, G. K., & Solanki, H. K. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.01.067 · Cited by 383
RetractedThe Antiviral Activities and Mechanisms of Marine Polysaccharides: An Overview
Wang, W., Wang, S.-X., & Guan, H.-S. (2012) · Marine Drugs · doi:10.3390/md10122795 · Cited by 381
Metadata
- Authors
- Grassauer, A., Weinmuellner, R., Meier, C., Pretsch, A., Prieschl-Grassauer, E., & Unger, H.
- Venue
- Virology Journal
- Published
- 2008
- Volume
- 5
- Issue
- 1
- Pages
- 107
- ISSN
- 1743-422X (ISSN-L)
- OpenAlex
- W2157546837
- Cited by
- 217
- References
- 4
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Iota-Carrageenan is a potent inhibitor of rhinovirus infection. https://app.cochat.ai/papers/10.1186/1743-422x-5-107
- The paper
- Grassauer, A., Weinmuellner, R., Meier, C., Pretsch, A., Prieschl-Grassauer, E., & Unger, H. (2008). Iota-Carrageenan is a potent inhibitor of rhinovirus infection. Virology Journal. https://doi.org/10.1186/1743-422x-5-107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.